One of the simplest questions that can be asked about molecular diversity is how many organic molecules are possible in total? To answer this question, my research group has computationally enumerated all possible organic molecules up to a certain size to gain an unbiased insight into the entire chemical space. Our latest database, GDB-17, contains 166.4 billion molecules of up to 17 atoms of C, N, O, S, and halogens, by far the largest small molecule database reported to date. Molecules allowed by valency rules but unstable or nonsynthesizable due to strained topologies or reactive functional groups were not considered, which reduced the enumeration by at least 10 orders of magnitude and was essential to arrive at a manageable database size. Despite these restrictions, GDB-17 is highly relevant with respect to known molecules. Beyond enumeration, understanding and exploiting GDBs (generated databases) led us to develop methods for virtual screening and visualization of very large databases in the form of a "periodic system of molecules" comprising six different fingerprint spaces, with web-browsers for nearest neighbor searches, and the MQN-and SMIfp-Mapplet application for exploring colorcoded principal component maps of GDB and other large databases. Proof-of-concept applications of GDB for drug discovery were realized by combining virtual screening with chemical synthesis and activity testing for neurotransmitter receptor and transporter ligands. One surprising lesson from using GDB for drug analog searches is the incredible depth of chemical space, that is, the fact that millions of very close analogs of any molecule can be readily identified by nearest-neighbor searches in the MQN-space of the various GDBs. The chemical space project has opened an unprecedented door on chemical diversity.
■ INTRODUCTION
Organic molecules are defined by the number, type, topological connectivity, and stereochemistry of atoms described by their structural formula. As of today over one hundred million such organic molecules have been prepared, mostly in the context of medicinal chemistry. 1, 2 Cheminformatics provides various computational tools to handle the massive amount of information created by these millions of molecules, in particular to enable database classification and bioactivity prediction. 3−7 One of the simplest questions that can be asked about molecular diversity is how many organic molecules are possible in total? The so-called "drug-like" chemical space has been estimated at 10 60 for all molecules obeying Lipinski's rule-offive for oral bioavailability, 8, 9 and at 10 20 −10 24 for all molecules up to 30 atoms, 10 in any case a number far too large for practical application. 11 Nevertheless my research group has undertaken the computational enumeration of all possible organic molecules up to a certain size. Our goal was not only to count molecules but also to write them down as SMILES, 4 to understand their diversity, and to test their possible relevance for drug discovery. This "chemical space project" led to the chemical universe databases (GDBs, generated databases) enumerating molecules following criteria for size, chemical stability, and synthetic feasibility. This Account follows previous reviews 12−15 and provides a perspective on our work on database assembly, visualization, and drug discovery.
■ ENUMERATION
Organic molecules can be derived from mathematical graphs by substituting atoms for graph nodes and chemical bonds for graph edges. In 1875 Cayley, the inventor of graph theory, reported the first application of this principle by estimating the number of possible acyclic branched hydrocarbons as a function of size, 16−18 an approach later followed for other topologies. 19, 20 Beyond counting, structure enumeration algorithms such as MOLGEN 21, 22 have been produced to enable computer-assisted structure elucidation (CASE) 23−26 by enumerating molecules fitting predefined criteria of elemental composition, mass, and the presence or absence of functional groups. Other types of structure generators such as SPROUT 27 are genetic algorithms that evolve organic molecules for maximum docking to a target protein or highest similarity to a reference molecule. 28 In these algorithms, molecules are often assembled from known building blocks using known coupling reactions, an approach also used to enumerate virtual combinatorial libraries, 29−32 in particular the Pfizer Global Virtual Library, which corresponds to 10 trillion molecules, although the compounds are only enumerated in response to specific searches. 33 In contrast to the above tailored approaches, we set out to enumerate all possible molecules to gain an unbiased insight into the entire chemical space, taking only simple chemical stability and synthetic feasibility criteria into account. Starting with mathematical graphs produced by the program GENG, 34 graphs suitable to build saturated hydrocarbons were selected taking ring strain and topology into account, for example, excluding hydrocarbons with planar or pyramidal quaternary centers. These graphs were then converted to skeletons by introducing unsaturations following rules for valency, aromaticity, and ring strain, for example, excluding bridgehead double bonds and allenes. Finally molecules were obtained by mutating carbon atoms to N, O, S, and halogens taking functional group stability into account, for example, excluding water-reactive groups such as acyl chlorides, anhydrides, hemiacetals, enols, and enamines, and all heteroatom−heteroatom bonds except within aromatic rings, oximes, and hydrazones. Following our initial databases GDB-11 35, 36 and GDB-13, 37 we recently enumerated 166.4 billion molecules of up to 17 atoms of C, N, O, S, and halogens collected in GDB-17, by far the largest database of explicitly enumerated small molecules reported to date ( Figure 1A) . 38, 39 Related databases of enumerated aromatic heterocycles have been reported by others. 40, 41 Removing molecules allowed by valency rules but unstable or nonsynthesizable due to strained topologies or reactive functional groups as discussed above reduced the enumeration by at least 10 orders of magnitude and was therefore essential to arrive at a manageable database size. Despite these restrictions, GDB-17 is highly relevant with respect to known molecules. It contains approximately 60% of PubChem, ChEMBL, and Drugbank molecules up to 17 atoms, the remaining 40% featuring mostly molecules with nonenumerated elements (P, B, Si) and functional groups ( Figure 1B) . The unfiltered database of all valency-allowed C, N, and O compounds up to nine atoms is available for download at www. gdb.unibe.ch under the name DMU9 ("dark-matter universe").
GDB molecules are stored as SMILES representing 2D structures, which can be expanded to stereoisomers using the 3D-generator CORINA. 42 They are mostly stereochemically rich molecules of intermediate polarity with a three-dimensional molecular shape, 43 a property that is rather rare in historical drugs but correlates with clinical success of drug candidates ( Figure 1C) . 44 Most strikingly, enumeration results in a large diversity of structural types that are otherwise rather difficult to access, as exemplified by millions of isomers of marketed drugs, many of which have a very close pharmacophore and shape yet have never been reported, and by many yet unknown ring systems (compounds 1−12, Figure  1D ,E).
Enumerating organic molecules beyond GDB-17 represents an ongoing challenge and probably cannot be done exhaustively. One approach for sampling this larger chemical space consists in mutating known molecules from first principles to generate new structures. 45−47 In our "chemical space travel" (CST) algorithm, 48 iterative cycles of structural mutations on a starting molecule A coupled to selection by similarity to a target molecule B produces trajectory libraries of hundreds of thousands of intermediates representing the chemical space between start and target, an approach suitable for connecting between various molecules up to 50 atoms in a few tens of successive mutations ( Figure 2A ). CST was used to identify a strongly docking hybrid molecule 13 between AMPA and CNQX as a possible partial agonist of the AMPA receptor ( Figure 2B ). This approach was recently exploited by others to generate random molecules as a way to explore chemical space. 49 
■ A PERIODIC SYSTEM OF MOLECULES
The GDB databases complement other large databases of organic molecules of interest in drug discovery, flavors, and fragrances chemistry, which together populate the known and unknown chemical space of organic molecules (Table 1) . A classification system would be desirable to efficiently search for analogs and to visualize the diversity of such large databases. To address this challenge, we followed the concept of property spaces by which molecules are assigned numerical descriptor values, collected in a so-called fingerprint, 5 and placed at the corresponding coordinates of a multidimensional space where each dimension represents one of the descriptors. 50 In such property spaces, spatial proximity between molecules measures similarity. 51 Furthermore, principal component analysis (PCA) allows one to represent the property space by projection into the principal component plane (PC1, PC2), the mathematical equivalent of taking a picture from the most favorable angle ( Figure 3A) . 52−58 Inspired by the periodic system of the elements, organized according to the atomic and main quantum numbers to form a table such that nearby elements have related properties, we devised the MQN system in the form of a multidimensional grid. Molecules were assigned to grid positions following the values of 42 molecular quantum numbers (MQN) counting features important for chemical structure and biological activity. 73, 74 This MQN-system was enabled by a web-browser capable of identifying nearest neighbors of any molecule within seconds. 15, 72 The same principle was applied with another five fingerprints providing different insights into molecular structure, namely, the SMILES fingerprint (SMIfp) counting 34 characters appearing in the SMILES of a molecule, 75 the 1024-bit binary Daylight type substructure fingerprint (Sfp) 76 and extended connectivity fingerprint (ECfp4) 77 counting the presence of specific substructures, the atom pair fingerprint (APfp) encoding molecular shape, and its related category extended atom pair fingerprint (Xfp) encoding pharmacophores. 78 Validation with sets of known bioactive molecules such as the directory of useful decoys (DUD) 79 and shape analogs showed that nearest neighbor searches by city-block distance in each of these six fingerprint spaces efficiently retrieved bioactive analogs. For the case of MQN, SMIfp, APfp, and Xfp fingerprints similarity retrieved "scaffold-hopping" analogs, which are molecules with similar shape, pharmacophores, and bioactivity but very different substructures as measured by Sfp indicating nonobvious and valuable structure− activity relationships. 80 For MQN and SMIfp chemical spaces, PCA projects over 70% of data variability into the (PC1, PC2)-plane, making this plane suitable as map of chemical diversity. Color-coding according to molecular properties, such as molecule size, rigidity, and polarity, allows visualizing chemical diversity in various databases such as PubChem, 81 DrugBank, 82 and GDB-13. 72 Each pixel in these maps can be inspected by zooming and visualizing the molecules at that position with help of the MQN-and SMIfp-mapplets ( Figure 3B ). These java applications are freely available at www.gdb.unibe.ch to visualize DrugBank, ChEMBL, ZINC, PubChem, GDB-11, GDB-13, and GDB-17. 75, 83 The mapplets also contain molecule localization functions and a link to the web-browser for proximity searching in the parent MQN-and SMIfp-space. A related Fragrance-mapplet application allows inspecting the Flavornet and Superscent databases and the related fragrancelike subsets of ZINC and GDB-13. 68 Taken together, the proximity search browsers and mapplets constitute a "periodic system of molecules" for exploring chemical space that to the best of our knowledge is unprecedented.
■ DRUG DISCOVERY
GDB contains almost exclusively (>99.9%) new molecules and therefore represents a vast reservoir of opportunities for drug discovery. Remarkably, the majority of GDB molecules fulfill drug-likeness, 8 lead-likeness, 84 and fragment likeness 85 criteria, mostly because graph diversity is highest with polycyclic rigid structures and because the introduction of heteroatoms gives the largest number of possibilities for intermediate ratios of heteroatom to carbon, resulting in many relatively rigid and polar molecules.
Our first projects exploited GDB-11 using a combination of substructure-guided compound selection and high-throughput docking, followed by synthesis and testing. We focused on neurotransmitter receptors and transporters because these targets can be modulated by very small molecules such as those found in GDB. Dipeptide 14 and diketopiperazine 15 were identified from a glycine analog search in GDB-11 as inhibitors of the glycine site of the NMDA receptor, 86, 87 and norbornane aspartic acid rac-16 was identified from an aspartate analog search as selective inhibitor of the glutamate transporter GLT-1, 88 in both cases via synthesis and evaluation of 20−30 test compounds (Figure 4) . A similar approach was used to select possible modulators of the nicotinic acetylcholine receptor (nAChR) combining the selective enumeration of analogs of PNU-282,987 89 from quinuclidine-like diamines in GDB-11 with docking to the acetylcholine binding protein. Synthesis of over 80 computationally selected analogs and testing led to the discovery of the competitive α7 nAChR inhibitor 17.
90,91
Due to the limited throughput of docking, which only allowed evaluation of 5% of the compounds selected from GDB-11 in the case of the nAChR project, a more direct virtual screening approach was envisioned exploiting the concept of chemical space classification discussed above. Analogs of the 3-aminoquinuclidine nucleus of PNU-282,987 were extracted from GDB-13 by constraining MQN values. Remarkably, only 344 quinuclidine-like diamines remained when imposing up to nine carbon atoms, exactly two nitrogen atoms, two cycles size 5−7, no unsaturations, a maximum of two acyclic carbon atoms only as amine substituents, and at least two bonds shared by two rings to enforce a globular shaped bicyclic diamine. Three of these 344 diamines were selected by shape similarity 82, 96 to PNU-282,987, novelty, and synthetic feasibility. The synthesis was demanding, but the approach was quite successful. Two of the selected compounds rac-18 and rac-19 together with 20 from the previous approach turned out to be positive allosteric modulators (PAM) of the α3β2 nAChR, an unprecedented activity type absent from PNU-282,987 but desirable to strengthen muscular contraction in elderly people suffering from sacropenia by reinforcing neurotransmission at the neuromuscular junction.
The suitability of the MQN selection for identifying bioactive analogs of PNU-282,987 from GDB was confirmed in a parallel study with nicotine. 92 Starting from the fact that 322 compounds from GDB-13 also annotated as nicotinic acetylcholine receptor activity in ChEMBL were much closer to nicotine in MQN-space (CBD MQN = 22.8 ± 12.5) than average GDB-13 molecules (CBD MQN = 38.8 ± 11.1), a nearest neighbor selection was performed in the simplicity-selected GDB-13 subset (Table 1) , leading to 31 504 nicotine analogs. Sixty of these were purchased from a commercial source and tested against the α7 nAChR, revealing a single agonist as the MQN-based nearest neighbor selection as a virtual screening tool recently provided us with an additional striking success in our search for α3β2 nAChR PAM ligands. 93 Led by the evidence that both agonist and PAM activities on the highly similar α7 and α3β2 nAChRs was best achieved with globular quinuclidine-type tertiary amines, an MQN search was performed in ChEMBL starting from the known α7 nAChR agonist PNU-282,987. Applying the distance constraint CBD MQN ≤ 12 previously found to ensure high pharmacophore and shape similarity gave only 115 analogs, 49 of which were 3-substituted quinuclidines. A visual inspection of these derivatives, which we named "chemical space walk" to highlight the simplicity of the exercise, revealed 2-chlorobenzyl-3-aminoquinuclidine 24 as an interesting yet unexplored compound family for nAChR. Synthesis of this and further derivatives in optically pure form and evaluation by electrophysiology led to 2-iodo derivative (R)-25 as a particularly potent α3β2 nAChR PAM, which is currently undergoing further pharmacological evaluation.
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The above examples illustrate that nearest neighbor searches in MQN and related fingerprint spaces allow the successful exploitation of very large compound databases such as the GDB, or more directly the commercially available compounds in ZINC or the documented bioactive compounds in ChEMBL. We recently established a public web-based multifingerprint browser for the ZINC database, by which nearest neighbors of any query molecule can be retrieved from ZINC in MQN, SMIfp, Sfp, and ECfp4 spaces. 94 This browser is publicly available at www.gdb.unibe.ch and can also cluster nearest neighbors to compose a focused list for purchase and evaluation as valuable help for drug discovery projects.
■ CONCLUSION AND OUTLOOK
The exploration of chemical space started in the 19th century as a counting game to evaluate its size. The advent of cheminformatics and powerful computers allowed us to perform an actual enumeration of molecules to produce the chemical universe databases, GDBs. The project required chemical expertise to choose a set of criteria to select molecules with likely chemical stability and synthetic feasibility. The size of 166.4 billion structures for the currently largest database GDB-17 was mostly determined by the available computational power, data transfer rates, and memory size. Beyond enumeration, understanding and exploiting GDB led us to develop methods for virtual screening and visualization of very large databases in the form of a "periodic system of molecules" comprising six different fingerprint spaces, with web-browsers for nearest neighbor searches, and the MQN-and SMIfpMapplet application for exploring color-coded PC-maps of GDB and other large databases. Further insights into GDB molecules from the point of view of physical chemistry were recently reported by von Lilienfeld et al. in form of calculated electronic properties, which were predicted by machine learning methods. 95−97 Proof-of-concept applications of GDB for drug discovery were realized by combining virtual screening with chemical synthesis and activity testing for neurotransmitter receptor and transporter ligands. One surprising lesson from using GDB for drug analog searches is the incredible depth of chemical space, that is, the fact that millions of very close analogs of any molecule are possible including scaffold-hopping molecular shape and pharmacophore analogs. These analogs can be readily identified by nearest-neighbor searches in the MQNspace of the various GDBs and may display differentiated pharmacology as exemplified with the discovery of α3β2 nAChR PAM compounds discussed above.
The chemical space project has opened an unprecedented door on chemical diversity. Ongoing and yet unmet challenges concern enumerating molecules beyond 17 atoms and synthesizing GDB molecules with innovative scaffolds and pharmacophores. In the latter case, a quantum leap in the accuracy of virtual screening predictions would be most welcome since it would greatly increase the attractiveness of challenging GDB molecules for which creative synthetic routes must be designed.
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